Cocrystal Pharma, Inc. (COCP)

1.15 0.00 (0.00%) USD  |  NASDAQ  |  Sep 25, 14:26
More

Cocrystal Pharma Cash and Short Term Investments (Quarterly) : 2.244M for June 30, 2026

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for COCP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2008. Start Trial.
Date Value
June 30, 2026 2.244M
March 31, 2026 4.76M
December 31, 2025 7.10M
September 30, 2025 7.804M
June 30, 2025 4.841M
March 31, 2025 6.996M
December 31, 2024 9.935M
September 30, 2024 13.10M
June 30, 2024 18.22M
March 31, 2024 21.92M
December 31, 2023 26.43M
September 30, 2023 29.81M
June 30, 2023 32.49M
March 31, 2023 34.06M
December 31, 2022 37.22M
September 30, 2022 42.13M
June 30, 2022 51.11M
March 31, 2022 54.84M
December 31, 2021 58.76M
September 30, 2021 61.69M
June 30, 2021 67.11M
March 31, 2021 33.33M
December 31, 2020 33.06M
September 30, 2020 31.83M
June 30, 2020 19.36M
Date Value
March 31, 2020 21.74M
December 31, 2019 7.468M
September 30, 2019 6.044M
June 30, 2019 7.524M
March 31, 2019 8.621M
December 31, 2018 2.752M
September 30, 2018 4.713M
June 30, 2018 6.87M
March 31, 2018 1.278M
December 31, 2017 0.777M
September 30, 2017 1.345M
June 30, 2017 3.451M
March 31, 2017 1.555M
December 31, 2016 3.64M
September 30, 2016 5.906M
June 30, 2016 5.022M
March 31, 2016 10.24M
December 31, 2015 9.276M
September 30, 2015 12.41M
June 30, 2015 15.78M
March 31, 2015 15.25M
December 31, 2014 5.945M
September 30, 2014 5.506M
June 30, 2014 9.793M
March 31, 2014 9.884M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
CNBX Pharmaceuticals, Inc. 0.0095M
GB Sciences, Inc. --
Arvinas, Inc. 567.90M
Fulcrum Therapeutics, Inc. 318.84M
Definium Therapeutics, Inc. 1.084B